Breaking News Instant updates and real-time market news.

DGX

Quest Diagnostics

$93.10

7.93 (9.31%)

, UNH

UnitedHealth

$230.51

3.37 (1.48%)

07:13
04/24/19
04/24
07:13
04/24/19
07:13

Quest Diagnostics price target raised to $103 from $97 at Canaccord

Canaccord analyst Mark Massaro raised his price target for Quest Diagnostics (DGX) to $103 from $97 and reiterated a Buy rating after the company delivered a "solid" Q1 top and bottom line beat, driven by stronger volume growth than the Street anticipated. Quest is off to a "good start" as it adds new volume growth related to 43M new lives from recent health plan wins from UnitedHealthcare (UNH) and others, and Quest expects volumes to gradually grow throughout this year, Massaro tells investors in a research note.

DGX

Quest Diagnostics

$93.10

7.93 (9.31%)

UNH

UnitedHealth

$230.51

3.37 (1.48%)

  • 02

    May

  • 04

    May

  • 07

    May

  • 14

    May

  • 29

    May

  • 31

    May

  • 23

    Jun

DGX Quest Diagnostics
$93.10

7.93 (9.31%)

04/02/19
JEFF
04/02/19
UPGRADE
Target $107
JEFF
Buy
Quest, LabCorp upgraded to Buy ahead of UnitedHealth lab network rollout
Jefferies analyst Brian Tanquilut upgraded both Quest Diagnostics (DGX) and Laboratory Corp. of America (LH) to Buy from Hold on the belief that UnitedHealth's (UNH) rollout on July 1 of its preferred lab network will be a positive catalyst for both stocks. Quest and LabCorp's likely inclusion should bolster their organic growth beginning in 2020, Tanquilut tells investors in a research note. The analyst finds both stocks "compelling" with their 2019 outlooks "seemingly de-risked with fairly conservative guidance ranges" and 2020 consensus estimates "looking conservative." Further, Quest's and LabCorp's valuations are at below-historical relative averages, Tanquilut contends. The analyst raised his price target for Laboratory Corp. to $190 from $154 and for Quest to $107 from $93.
04/02/19
WOLF
04/02/19
INITIATION
WOLF
Underperform
Quest Diagnostics initiated with an Underperform at Wolfe Research
Wolfe Research started Quest Diagnostics with an Underperform rating and $83 price target, citing concerns about the 2021 impact of PAMA and the view that almost all of its free cash flow is "spoken for" over the next few years.
04/02/19
04/02/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Exelon (EXC) upgraded to Outperform from Market Perform at Wells Fargo with analyst Neil Kalton saying a key tenant to his thesis is that ExGen's nuclear fleet operates through the end of the units' various license extension periods, which will likely require additional policy support. 2. CommScope (COMM) upgraded to Outperform from Neutral at Credit Suisse with analyst Sami Badri citing fundamental strength in the combined business computed in his updated CommScope-Arris (ARRS) merger model with the Arris acquisition expected to close in April 2019. 3. Quest Diagnostics (DGX) and LabCorp (LH) upgraded to Buy from Hold at Jefferies. 4. Hostess Brands (TWNK) upgraded to Buy from Hold at Deutsche Bank with analyst Rob Dickerson saying management execution, a turnaround to profitability in the Chicago bakery and improved pricing could return Hostess to "top-tier revenue growth" this year. 5. Amphenol (APH) upgraded to Buy from Hold at SunTrust with analyst William Stein saying in a world of uncertainty, Amphenol offers more dependable upside. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
04/23/19
BNCH
04/23/19
NO CHANGE
BNCH
UnitedHealth preferred lab launch a long-term plus for Invitae, says Benchmark
Benchmark analyst Bruce Jackson noted that UnitedHealthcare (UNH) plans to launch a Preferred Laboratory Network to include Invitae (NVTA), which he views as a long-term positive for the latter and "another building block for Invitae's strategy to make genetic testing more widely available and more easily reimbursed." Other labs named to the preferred network include LabCorp (LH), Quest Diagnostics (DGX), and BioReference and GeneDx, which are both part of Opko (OPK), the analyst noted. UnitedHealthcare's current network includes NeoGenomics (NEO) and he doesn't anticipate any impact to NeoGenomics from the preferred network launch, added Jackson.
UNH UnitedHealth
$230.51

3.37 (1.48%)

04/17/19
RBCM
04/17/19
NO CHANGE
Target $83
RBCM
Outperform
eHealth selloff not related to company specific news, says RBC Capital
RBC Capital analyst Frank Morgan says he's found no company specific news that would explain the weakness today in shares of eHealth. Rather, the analyst attributes the 22% pullback to continued selling in managed care operators and providers, which began yesterday morning. He attributes yesterday's sell-off to Democratic presidential candidate rhetoric around Medicare-for-All, including a tweet from candidate Bernie Sanders during UnitedHealth's Q1 earnings call advocating for MFA. Morgan believes investors were looking to take profits in any strong year-to-date performers, like eHealth. The analyst has an Outperform rating on the stock with an $83 price target. eHealth in afternoon trading is down 22%, or $14.05, to $51.38.
04/18/19
LEER
04/18/19
NO CHANGE
LEER
Medicare-For-All risk overblown, investors should buy MCOs, says SVB Leerink
SVB Leerink analyst Ana Gupte believes Medicare-For-All risk is overblown, not the same as 2008/09, and recommends investors step in now to buy MCOs. The analyst believes it is a "once in a decade opportunity" to get high quality names at these depressed multiples, with UnitedHealth (UNH), Anthem (ANTM), and Humana (HUM) being her favorites.
04/23/19
UBSW
04/23/19
INITIATION
Target $238
UBSW
Neutral
UnitedHealth initiated with a Neutral at UBS
UBS analyst Whit Mayo started UnitedHealth with a Neutral rating and $238 price target, saying its sector is "dominated by exogenous factors" such as the election, policy uncertainty, and a pending ACA litigation. The analyst notes that the stock has more upside than downside in the near term, but also believes that the Street consensus has priced in UnitedHealth's long-term growth and the trend of not having missed on its numbers in 10 years.

TODAY'S FREE FLY STORIES

11:55
06/24/19
06/24
11:55
06/24/19
11:55
General news
Treasury's $72 B 3- and 6-month bill auctions were ok but sloppy »

Treasury's $72 B 3-…

INGN

Inogen

$72.22

0.93 (1.30%)

11:55
06/24/19
06/24
11:55
06/24/19
11:55
Conference/Events
William Blair medical tech analyst to hold a luncheon »

Medical Technology…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 26

    Aug

GTLS

Chart Industries

$70.49

0.33 (0.47%)

11:54
06/24/19
06/24
11:54
06/24/19
11:54
Conference/Events
Chart Industries management to meet with Seaport Global »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 25

    Jun

  • 26

    Jun

  • 11

    Jul

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

, SPX

S&P 500

$0.00

(0.00%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
General news
Trump signing executive order for 'strong sanctions' on Iran, Bloomberg reports »

Bloomberg quotes…

SPY

SPDR S&P 500 ETF Trust

$294.30

0.31 (0.11%)

SPX

S&P 500

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HAL

Halliburton

$22.55

-0.28 (-1.23%)

11:50
06/24/19
06/24
11:50
06/24/19
11:50
Options
Halliburton trader exits late-may risk-reversal for a loss »

Halliburton trader exits…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 27

    Aug

  • 13

    Nov

KRYS

Krystal Biotech

$37.20

7.92 (27.05%)

11:46
06/24/19
06/24
11:46
06/24/19
11:46
Recommendations
Krystal Biotech analyst commentary  »

Krystal Biotech price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

TLRD

Tailored Brands

$6.11

0.565 (10.20%)

11:45
06/24/19
06/24
11:45
06/24/19
11:45
Options
Tailored Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.94

1.77 (1.19%)

, AAPL

Apple

$199.39

0.62 (0.31%)

11:44
06/24/19
06/24
11:44
06/24/19
11:44
Periodicals
Apple hits back at Spotify's claims of unfair App Store treatment, AI reports »

Apple (AAPL) is hitting…

SPOT

Spotify

$149.94

1.77 (1.19%)

AAPL

Apple

$199.39

0.62 (0.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
6-Month Bill Auction Total Amount data reported »

6-Month Bill Auction…

11:43
06/24/19
06/24
11:43
06/24/19
11:43
General news
3-Month Bill Auction Total Amount data reported »

3-Month Bill Auction…

OXFD

Oxford Immunotec

$13.88

-0.22 (-1.56%)

11:37
06/24/19
06/24
11:37
06/24/19
11:37
Hot Stocks
Oxford Immunotec appoints Patrick Balthrop, Sr. as Chairman »

Oxford Immunotec…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPOT

Spotify

$149.99

1.82 (1.23%)

, DE

Deere

$167.23

2.94 (1.79%)

11:33
06/24/19
06/24
11:33
06/24/19
11:33
On The Fly
Spotify downgrade, Deere upgrade among today's top analyst calls »

Check out today's top…

SPOT

Spotify

$149.99

1.82 (1.23%)

DE

Deere

$167.23

2.94 (1.79%)

AGCO

Agco

$76.63

1.92 (2.57%)

IP

International Paper

$42.49

-1.13 (-2.59%)

OXY

Occidental Petroleum

$49.84

-0.78 (-1.54%)

APC

Anadarko

$70.20

-0.17 (-0.24%)

OAS

Oasis Petroleum

$5.45

-0.27 (-4.72%)

SHOP

Shopify

$315.91

-10.77 (-3.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jun

  • 24

    Jun

  • 25

    Jun

  • 26

    Jun

  • 10

    Jul

  • 17

    Jul

  • 27

    Aug

  • 04

    Sep

  • 05

    Sep

  • 05

    Sep

FB

Facebook

$193.42

2.26 (1.18%)

11:30
06/24/19
06/24
11:30
06/24/19
11:30
Options
Lots of likes for short-term Facebook upside calls »

Lots of likes for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Jul

  • 16

    Jul

SIG

Signet Jewelers

$17.49

-0.13 (-0.74%)

11:25
06/24/19
06/24
11:25
06/24/19
11:25
Options
Signet Jewelers call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVTY

Tivity Health

$17.18

-0.23 (-1.32%)

11:24
06/24/19
06/24
11:24
06/24/19
11:24
Conference/Events
Tivity Health management to meet with SunTrust »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 14

    Aug

  • 15

    Aug

11:20
06/24/19
06/24
11:20
06/24/19
11:20
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

11:17
06/24/19
06/24
11:17
06/24/19
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is above average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

11:16
06/24/19
06/24
11:16
06/24/19
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UPS

UPS

$100.87

-1.29 (-1.26%)

11:15
06/24/19
06/24
11:15
06/24/19
11:15
Options
UPS put volume heavy and directionally bearish »

Bearish flow noted in UPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jun

  • 26

    Jun

  • 24

    Jul

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

11:15
06/24/19
06/24
11:15
06/24/19
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

, PFE

Pfizer

$43.59

-0.09 (-0.21%)

11:11
06/24/19
06/24
11:11
06/24/19
11:11
On The Fly
Before the Move: Watch Sarepta ahead of Pfizer's DMD gene therapy data »

Ahead of the Parent…

SRPT

Sarepta

$127.90

-2.01 (-1.55%)

PFE

Pfizer

$43.59

-0.09 (-0.21%)

SLDB

Solid Biosciences

$4.91

-0.07 (-1.41%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 19

    Aug

  • 28

    Aug

  • 16

    Sep

GLW

Corning

$33.15

-0.1 (-0.30%)

11:08
06/24/19
06/24
11:08
06/24/19
11:08
Recommendations
Corning analyst commentary at JPMorgan »

Drop in LCD TV panel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSN

Tyson Foods

$81.18

1.87 (2.36%)

11:05
06/24/19
06/24
11:05
06/24/19
11:05
Options
Tyson Foods call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

, CELG

Celgene

$94.16

-4.76 (-4.81%)

10:59
06/24/19
06/24
10:59
06/24/19
10:59
Periodicals
Bristol-Myers' merger headaches could be 'contagious,' STAT News says »

Bristol-Myers Squibb…

BMY

Bristol-Myers

$45.86

-3.5 (-7.09%)

CELG

Celgene

$94.16

-4.76 (-4.81%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jun

  • 25

    Jul

  • 03

    Sep

  • 16

    Sep

  • 04

    Dec

  • 25

    Mar

  • 04

    Apr

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.